| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/23/2006 | WO2006019037A1 Method of judging liver fibrosis stage |
| 02/23/2006 | WO2005113827A3 Construction of live attenuated shigella vaccine strains that express cfa/i antigens (cfab and cfae) and the b subunit of heat-labile enterotoxin (ltb) from enterotoxigenic e. coli |
| 02/23/2006 | WO2005110475A3 Antibodies |
| 02/23/2006 | WO2005093422A3 Carbohydrate-encapsulated quantum dots for biological imaging |
| 02/23/2006 | WO2005089795A3 Infectious bursal disease virus antigenic isolates and vaccines |
| 02/23/2006 | WO2005064021A3 Vaccine |
| 02/23/2006 | WO2005061538A3 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 02/23/2006 | WO2005059546A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 35 (gpr35) |
| 02/23/2006 | WO2005058815A3 Ip-10 antibodies and their uses |
| 02/23/2006 | WO2005052128A3 Mrna transfected antigen presenting cells |
| 02/23/2006 | WO2004108885A3 Fc chimeric proteins with anti-hiv drugs |
| 02/23/2006 | WO2004078137A3 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 02/23/2006 | WO2004074310A3 Mycobacterial diagnostics |
| 02/23/2006 | WO2004071458A3 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 02/23/2006 | WO2004012685A3 Shed antigen vaccine with dendritic cells adjuvant |
| 02/23/2006 | WO2003089453A3 INHIBITION OF Ii EXPRESSION IN MAMMALIAN CELLS |
| 02/23/2006 | WO2003086277A9 Attenuated gram negative bacteria |
| 02/23/2006 | US20060041219 Method for muscle delivery of drugs, nucleic acids and other compounds |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040893 Immunomodulatory methods using oligosaccharides |
| 02/23/2006 | US20060040891 Lipid a and other carbohydrate ligand analogs |
| 02/23/2006 | US20060040883 Methods for treating cancer using anti-Wnt2 monoclonal antibodies and siRNA |
| 02/23/2006 | US20060040878 Bacterial antigen induced bone morphogenesis |
| 02/23/2006 | US20060040382 Tagged epitope protein transposable element |
| 02/23/2006 | US20060040371 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 02/23/2006 | US20060040357 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 02/23/2006 | US20060040310 Epitope testing using soluble HLA |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040302 Methods of classifying, diagnosing, stratifying and treating cancer patients and their tumors |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060039987 Method and apparatus for producing dry particles |
| 02/23/2006 | US20060039962 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting |
| 02/23/2006 | US20060039930 Methods for enhancing wound healing |
| 02/23/2006 | US20060039929 Chimera botulinum toxin type E |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039927 Specific binding agents for KSHV vIL-6 that neutralize a biological activity |
| 02/23/2006 | US20060039926 show reduced growth and pathogenicity in vivo; comprises a viral genome encoding a p59 protein having at mutation at a specific tyrosine residue; avian infectious bronchitis virus, bovine coronavirus, canine coronavirus, feline infectious peritonitis virus, human coronavirus 229E, human coronavirus OC43 |
| 02/23/2006 | US20060039925 Mutants of streptococcal toxin a and methods of use |
| 02/23/2006 | US20060039924 Peptide having modified arginine residue; detecting autoimmune antibodies against rheumatoid arthritis |
| 02/23/2006 | US20060039923 Vaccine for preventing and treating porcine progressive atrophic rhinitis |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039921 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus |
| 02/23/2006 | US20060039920 Immunization, scrub typhus of tsutsugamushi disease, HIV |
| 02/23/2006 | US20060039919 an E7 peptide sequence of human papillomavirus type 16, a translocation peptide and a peptide within a carboxyl terminal fragments, used for inhibiting urogenital cancers induced or caused by HPV type 16 |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039917 Method for treating phantom pain by peripheral administration of a neurotoxin |
| 02/23/2006 | US20060039916 Method for treating complex regional pain by peripheral administration of a neurotoxin |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039914 Anti-cancer activity of an anti-thymidine kinase monoclonal antibody |
| 02/23/2006 | US20060039913 Monoclonal antibody inhibits ability of monocyte chemoattractant protein (MCP) to cause chemotactic migration to monocytic cells and prevents calcium mobilization; diagnosis and treatment of prostate and colon cancer |
| 02/23/2006 | US20060039912 Antibodies to adipose tissues |
| 02/23/2006 | US20060039911 Method for the treatment of gastroesophageal reflux disease |
| 02/23/2006 | US20060039910 Methods and compositions for treating allergic inflammation |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039908 cancer associated antigen, transferrin receptor; diagnosing and treating various human cancers and diseases that express transferrin receptor |
| 02/23/2006 | US20060039907 Method and compositions for treating diseases targeting CD71 |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/23/2006 | US20060039905 Galectin 11 |
| 02/23/2006 | US20060039904 Erythropoietin-Producing human Hepatocellular (Eph) receptor A2; cancer, inflammatory and autoimmune diseases |
| 02/23/2006 | US20060039903 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 02/23/2006 | US20060039902 Antagonizing interleukin-21 receptor activity |
| 02/23/2006 | US20060039901 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/23/2006 | US20060039900 Epitope directed selection of antibodies to murine tissue factor |
| 02/23/2006 | US20060039899 Animal nutritional product that increases weight gain and reduces diarrhea morbidity, mortality and severity by stimulation of natural immune response, nutritional support of immune function and supplemental nutricines and probiotics |
| 02/23/2006 | US20060039897 transforming a stinging cell or stinging cell progenitor with a polynucleotide encoding a therapeutic, cosmetic or diagnostic agent to thereby generate at least one stinging cell expressing therapeutic, cosmetic or diagnostic agent in the stinging cell (derived from Cnidaria, Dinoflagelleaa) |
| 02/23/2006 | CA2777686A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2578189A1 Method for determining dosage for an oral killed vaccine |
| 02/23/2006 | CA2577692A1 Methods and compositions for treatment of hematologic cancers |
| 02/23/2006 | CA2577597A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 02/23/2006 | CA2577183A1 Mutated hiv nef for modulating immunity |
| 02/23/2006 | CA2576886A1 Tie complex binding proteins |
| 02/23/2006 | CA2576867A1 Ileitis diagnostic assay |
| 02/23/2006 | CA2576672A1 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 02/23/2006 | CA2575689A1 Tr1 cells for use in atherosclerosis |
| 02/23/2006 | CA2575563A1 Combination therapy for diabetes, obesity, and cardiovascular diseases using gdf-8 inhibitors |
| 02/23/2006 | CA2575163A1 Adenoviral vector compositions |
| 02/23/2006 | CA2574488A1 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 02/23/2006 | CA2573192A1 Variant fc regions |
| 02/23/2006 | CA2569235A1 Anti-ghrelin antibodies |
| 02/23/2006 | CA2565961A1 Optimized fc variants |
| 02/23/2006 | CA2478456A1 Combination therapy |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627918A1 Antagonists of interleukin-15 |
| 02/22/2006 | EP1627886A1 Polypeptide, cDNA encoding the same, and use of them |
| 02/22/2006 | EP1627643A2 Vascular endothelial cell growth factor antagonists |
| 02/22/2006 | EP1627217A2 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 02/22/2006 | EP1627047A2 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 02/22/2006 | EP1627046A2 Domain-exchanged binding molecules, methods of use and methods of production |
| 02/22/2006 | EP1626991A2 Anti alpha-folate-receptor-tetramer antibodies |
| 02/22/2006 | EP1626737A2 Method of enhanced immunogenicity to meningococcal vaccination |
| 02/22/2006 | EP1626708A2 Immunogenic reagents from west nile virus |
| 02/22/2006 | EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 02/22/2006 | EP1441735B1 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/22/2006 | EP1370668B1 Leporipox-based vector vaccines |
| 02/22/2006 | EP1320300B1 Food supplement |
| 02/22/2006 | EP1244803B1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 02/22/2006 | EP1212464B1 Diagnostics and therapeutics for osteoporosis |
| 02/22/2006 | EP1121156B1 Polymer conjugates of interferon beta- 1a and their uses |
| 02/22/2006 | EP1109564B1 Method for removal of hiv and other viruses from blood |
| 02/22/2006 | EP1042450B1 Isolated strains of staphylococcus aureus and vaccines manufactured therefrom |